Cargando…

Analysis of Environmental Chemical Mixtures and Non-Hodgkin Lymphoma Risk in the NCI-SEER NHL Study

BACKGROUND: There are several suspected environmental risk factors for non-Hodgkin lymphoma (NHL). The associations between NHL and environmental chemical exposures have typically been evaluated for individual chemicals (i.e., one-by-one). OBJECTIVES: We determined the association between a mixture...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czarnota, Jenna, Gennings, Chris, Colt, Joanne S., De Roos, Anneclaire J., Cerhan, James R., Severson, Richard K., Hartge, Patricia, Ward, Mary H., Wheeler, David C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NLM-Export 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590749/ https://www.ncbi.nlm.nih.gov/pubmed/25748701 http://dx.doi.org/10.1289/ehp.1408630

Ejemplares similares

Spatial-temporal analysis of non-Hodgkin lymphoma in the NCI-SEER NHL case-control study
por: Wheeler, David C, et al.
Publicado: (2011)

A Case–Control Study of Occupational Exposure to Trichloroethylene and Non-Hodgkin Lymphoma
por: Purdue, Mark P., et al.
Publicado: (2011)

Herbicide use in farming and other jobs in relation to non-Hodgkin’s lymphoma (NHL) risk
por: De Roos, Anneclaire J, et al.
Publicado: (2022)

Residential proximity to industrial combustion facilities and risk of non-Hodgkin lymphoma: a case–control study
por: Pronk, Anjoeka, et al.
Publicado: (2013)

Correction to: Residential proximity to industrial combustion facilities and risk of non-Hodgkin lymphoma: a case-control study
por: Pronk, Anjoeka, et al.
Publicado: (2021)

Assessment of Weighted Quantile Sum Regression for Modeling Chemical Mixtures and Cancer Risk
por: Czarnota, Jenna, et al.
Publicado: (2015)

Non-Hodgkin Lymphoma (NHL) in Pakistan
por: Pervez, Shahid
Publicado: (2012)

Variation in Effects of Non-Hodgkin Lymphoma Risk Factors According to the Human Leukocyte Antigen (HLA)-DRB1*01:01 Allele and Ancestral Haplotype 8.1
por: Wang, Sophia S., et al.
Publicado: (2011)

BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).
por: Butler, M., et al.
Publicado: (1997)

Familial Aggregation of Non-Hodgkin's Lymphoma (NHL). A Case Report
por: Loves, Sandra SCM, et al.
Publicado: (2006)

Evaluating Geographically Weighted Regression Models for Environmental Chemical Risk Analysis
por: Czarnota, Jenna, et al.
Publicado: (2015)

Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case–control study
por: Anderson, L A, et al.
Publicado: (2008)

Investigation of spatio-temporal cancer clusters using residential histories in a case–control study of non-Hodgkin lymphoma in the United States
por: Nordsborg, Rikke Baastrup, et al.
Publicado: (2015)

Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma
por: Gathany, Allison H., et al.
Publicado: (2009)

Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL).
por: Dorey, E. L., et al.
Publicado: (1989)

NHL - Extranodal T-cell lymphoma
por: Devi, Seema, et al.
Publicado: (2015)

Survival among AIDS patients with and without non-Hodgkin's lymphoma, and NHL-HIV-negative patients
por: Cornejo-Juárez, Patricia, et al.
Publicado: (2007)

B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS
por: Wang, Sophia S., et al.
Publicado: (2022)

Epidemiologic Evaluation of Measurement Data in the Presence of Detection Limits
por: Lubin, Jay H., et al.
Publicado: (2004)

The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
por: Chu, Yaya, et al.
Publicado: (2022)

Kaposi’s sarcoma-associated herpesvirus (KSHV) serum DNA not associated with subsequent non-Hodgkin’s lymphoma (NHL) risk
por: Beachler, Dan, et al.
Publicado: (2010)

Single Nucleotide Polymorphisms in MIR143 Contribute to Protection against Non-Hodgkin Lymphoma (NHL) in Caucasian Populations
por: Bradshaw, Gabrielle, et al.
Publicado: (2019)

Targeting Asparagine and Serine Metabolism in Germinal Centre-Derived B Cells Non-Hodgkin Lymphomas (B-NHL)
por: Eraslan, Zuhal, et al.
Publicado: (2021)

Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects
por: McDuffie, Helen H, et al.
Publicado: (2009)

SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression
por: Ten, Lik-Chin, et al.
Publicado: (2017)

Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
por: Knörr, Fabian, et al.
Publicado: (2021)

Innate Immunity and Non-Hodgkin’s Lymphoma (NHL) Related Genes in a Nested Case-Control Study for Gastric Cancer Risk
por: Park, Sue K., et al.
Publicado: (2012)

In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin’s lymphoma (NHL)
por: Aya-Bonilla, Carlos, et al.
Publicado: (2014)

Evaluation of Bone Mineral Density in Children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin's Lymphoma (NHL): Chemotherapy with/without Radiotherapy
por: Ghassemi, Ali, et al.
Publicado: (2016)

A case report of surgical management of a solitary Non-Hodgkin's Lymphoma (NHL) arising from the proximal sciatic nerve
por: Gobinath, Sivakumaran, et al.
Publicado: (2023)

Biomarkers in NHL
por: Malek, Sami N.
Publicado: (2011)

Anti-Spike (S) Antibody Production Post Covid-19 Vaccination after B Cell Depleting Therapy (BCDT) for Non-Hodgkin Lymphoma (NHL)
por: Molina, Josselyn Glamyr
Publicado: (2021)

Human Leukocyte Antigen Class I and II Alleles and Overall Survival in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
por: Lu, Yani, et al.
Publicado: (2011)

Primary B-cell non-Hodgkin lymphoma of the parotid gland: An analysis based on the SEER database
por: Chen, Xiang-Lei, et al.
Publicado: (2023)

Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin’s Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease
por: Huang, Shuang, et al.
Publicado: (2021)

Translation and Pilot Validation of the EORTC QLQ-NHL-HG29 Module in Indian Languages (Hindi and Marathi) for Use in Indian Patients with Non-Hodgkin's Lymphoma
por: Patil, Roshankumar, et al.
Publicado: (2022)

Racial Disparities in Survival Among Non-Hodgkin Lymphoma Patients: An Analysis of the SEER Database (2007-2015)
por: Abodunrin, Faith O, et al.
Publicado: (2022)

Polymorphisms in DNA Repair and One-Carbon Metabolism Genes and Overall Survival in Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma
por: Wang, Sophia S, et al.
Publicado: (2008)

Serum levels of several molecules that are associated with B cell activation and inflammation are elevated in AIDS-associated non-Hodgkin’s lymphoma (AIDS-NHL) and predict response to treatment
por: Epeldegui, Marta, et al.
Publicado: (2012)

ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort
por: Fernandes, Mara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2o3j2mjt94oc23vs2o3lui36r7